CrystaLens Accommodating IOL First To Market; Firm Eyes Expanded Labeling
This article was originally published in The Gray Sheet
Executive Summary
Eyeonics, Inc. will file a supplemental PMA for its CrystaLens AT-45 accommodating posterior chamber intraocular lens to broaden the treatment range beyond 1.0 diopter
You may also be interested in...
Bausch & Lomb Buys Eyeonics, Enters Premium IOL Market With Crystalens
Bausch & Lomb will enter the fast-growing premium intraocular lens market for the first time through its acquisition of Crystalens maker Eyeonics under a pact announced Jan. 20
Bausch & Lomb Buys Eyeonics, Enters Premium IOL Market With Crystalens
Bausch & Lomb will enter the fast-growing premium intraocular lens market for the first time through its acquisition of Crystalens maker Eyeonics under a pact announced Jan. 20
Eyeonics Eyes International Sales Force Creation With Planned IPO Proceeds
Premium intraocular lens maker Eyeonics will establish a direct sales force outside the United States and expand its domestic sales and marketing activities with the proceeds of a planned initial public stock offering